Bupa-owned Cromwell Hospital in London has introduced Aquablation therapy – a minimally invasive procedure that uses a robotically controlled waterjet to treat a symptomatic enlarged prostate.
Aquablation therapy uses an advanced robotic system called AquaBeam. It combines real-time imaging, automated robotic technology, and a heat-free waterjet to remove obstructive prostate tissue precisely and effectively.
Clinical trials have shown the technology is less likely to lead to side effects than other comparable treatments, in turn improving patient outcomes and their quality of life.
Neil Barber, consultant urological surgeon, who introduced the procedure to the UK in 2016, said: ‘I’m very pleased to be running the Aquablation service here at Cromwell Hospital. Since introducing this procedure into the UK, we’ve seen many benefits for those who have had the treatment, including speed and accuracy of the procedure as well as a faster return to normal activities. It is also less likely to cause damage to surrounding healthy tissues because it offers greater precision that other treatments for an enlarged prostate.
‘Many patients are often worried about the consequences of treatment on their sexual function. Aquablation therapy offers a lower rate of irreversible complications, such as incontinence, ejaculatory and erectile dysfunction, which is a real benefit to them.’
Cromwell Hospital CEO Philip Luce added: ‘We’re delighted to be offering Aquablation therapy at Cromwell Hospital. We’re always looking for new ways in which we can introduce innovative new treatments and technologies at the hospital so we’re meeting our patients ever changing needs.’
©2024 All rights reserved LaingBuisson 
